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stem cell; action potential; myocardial infarction STEM CELL THERAPY IS A PROMISING treatment strategy for patients with ischemic heart disease and has been associated with improved hemodynamic function (11, 16, 27, 29) . Despite the high risk of sudden cardiac death associated with ischemic heart disease, much of the electrophysiological focus of cell therapy has been on safety (i.e., proarrhythmia) (11, 16, 27) . Safety of cell therapy is clinically very important; however, very few reports have investigated the electrophysiological phenotype of stem cells in situ (18, 23, 26) .
In previous studies, our laboratory demonstrated that mesenchymal stem cell (MSC) therapy is associated with enhanced electrical viability (evidence of action potentials) in scarred myocardium when cells are administered at the time of an initial ischemic event (18, 31) . However, the mechanism of this enhancement is unclear. MSCs have been associated with cardiac-like properties (1, 13, 22, 30) and gap junction proteins responsible for electrical cell-to-cell coupling (14, 32) ; however, this finding is not universal, and in some settings MSCs can have a detrimental effect (2) . Another gap in knowledge is that, for many patients, stem cell therapy can only be administered after a previous ischemic event, when the infarct has already healed. In this setting, the chemical signals associated with acute ischemia are absent, and it is not clear if stem cells will even engraft. We hypothesize that MSCs delivered intramyocardially to cryoinjured myocardium will engraft but not actively generate action potentials.
MATERIALS AND METHODS
Experimental model. This investigation conforms to the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (NIH publication no. 85-23, revised 1996) and was approved by the Institutional Animal Care and Use Committee of both Case Western Reserve University and the Cleveland Clinic. Male Lewis rats, weighing 250 -300 g, were anesthetized with 3% isoflurane, intubated, and mechanically ventilated with room air at 80 breaths/min with a pressure-cycled rodent ventilator (Harvard Apparatus, model 683, Holliston, MA). The heart was exposed through a medial thoracotomy, and a cryoinjury was created on the left ventricle (LV) epicardial anterior wall of all animals by applying for 20 s a round 4-mm-diameter metal probe cooled to Ϫ80°C. Two groups of rats were utilized in this study: scar ϩ saline injection (sham, n ϭ 11) and scar ϩ MSC injection (MSC treated, n ϭ 16). In these groups, six and eight animals, respectively, were used for optical mapping studies, and the others for fixed tissue sample analysis and cell isolation.
MSC procedure. Rat bone marrow was isolated by flushing the femurs with 0.6 ml DMEM (GIBCO, Invitrogen, Carlsbad, CA). Clumps of bone marrow were gently minced with an 18-gauge needle and then centrifuged for 5 min at 260 g and washed with two changes of phosphate-buffered saline (PBS) (Invitrogen). The washed cells were then resuspended and plated in DMEM-LG (GIBCO, Invitrogen) with 10% FBS and 1% antibiotic and antimycotic (GIBCO, Invitrogen). The cells were incubated at 37°C, and nonadherent cells were removed by replacing the medium after 3 days. When cultures became 70% confluent, adherent cells were detached following incubation with 0.05% trypsin and 2 mM EDTA (Invitrogen) for 5 min. MSC cultures were then depleted of CD45ϩ and CD34ϩ cells simultaneously by negative selection using 10 l each of primary phycoerythrin-conjugated mouse anti-rat CD45 (BD Biosciences, San Diego, CA) and CD34 antibodies (Santa Cruz Biotechnology, Santa Cruz, CA) per 10 6 cells using the EasySep PE selection kit (Stem Cell Technologies). Finally, confluent cells were passaged and plated out at 1:4 to 1:5 dilutions until passage 12 (18) . Approximately 2 days before administration, cells were labeled with DiI (1,1=-dioctadecyl-3,3,3,3=-tetramethylindocarbocyanine perchlorate, Invitrogen). Just before administration, 2 ϫ 10 6 cells were suspended in 200 l of PBS.
Cells were intramyocardially injected just below (Ͻ1 mm) and parallel to the epicardial surface at three to four sites within the cryoinjury of each animal in the MSC-treated group. In the sham group, 200 l of PBS alone were injected in a similar fashion. Optical mapping. Optical mapping was performed in Langendorffperfused rat hearts 3 wk after cryoinjury, as described previously (17) . Rats were injected with 1,000 units ip heparin and then anesthetized with 250 mg/kg ip sodium pentobarbital. Hearts were excised and immersed in 34°C Tyrode solution containing (mM) 140 NaCl, 4.56 KCl, 0.73 MgCl 2, 10 HEPES, 5.0 dextrose, 1.25 CaCl2 and 20 2-3 butanedione monoxime (pH 7.4) in an optical recording chamber. To help determine the mechanisms of MSC action, detection of DiI fluorescence was performed before voltage staining (see below) using optical mapping techniques, as described previously (6) . This allowed the precise overlay of MSC engraftment with optical action potential activity.
For voltage staining, the heart was placed in 10 ml of ice-cold cardioplegia and 250 l of 4-{␤-[2-(di-n-butylamino)-6-naphthyl]-vinyl}pyridium (di-4-ANEPPS, voltage dye) for 30 min. The cardioplegia was bubbled with O 2 100% to gently agitate the heart and ensure uniform staining of the entire epicardial surface. After completion of staining, the aorta was cannulated and perfused with 33-34°C Tyrode solution (40 -60 mmHg). Electrocardiogram, perfusion pressure, and bath temperature were measured continuously during all experiments.
The optical mapping system used has been described in detail previously (17) . Briefly, action potentials were optically recorded at a magnification of ϫ2.1 from 256 sites within an 8.3-mm ϫ 8.3-mm mapping field (0.52-mm interpixel resolution) on the anterior epicardial surface of the LV. Fluorescence was excited with uniform light from multiple light guides using a 250-W QTH lamp (filtered 510 ϩ 40 nm) and transmitted to a 16 ϫ 16-element photodiode array (emission filter Ͼ610 nm), where fluorescence intensity measured at each photodiode was linearly converted to a voltage signal. Voltage signals were low-pass (500 Hz) filtered and had DC offset removal in hardware. Since di-4-ANNEPS emission (ϳ610 nm) does overlap with DiI emission (ϳ605 nm), it is possible that an offset will be added to the optically recorded action potentials. However, since offset is removed in hardware, this will not influence our results. A charge-coupled device camera that is optically aligned with the photodiode array was used to obtain DiI fluorescence and visible images of the optical mapping field relative to anatomical landmarks (e.g., scar and normal tissue). To eliminate motion artifact, 20 mM of 2,3-butanedione monoxime or 5 M blebbistatin were used.
Experimental protocol. All hearts were paced at steady-state cycle lengths of 200, 190, and 150 ms using a unipolar electrode placed on the epicardial surface at 2 ϫ threshold. While not the main objective of this study, arrhythmia vulnerability testing with programmed stimulation was performed with up to three premature stimuli. Inducibility was defined as the ability to provoke nonsustained or sustained (Ͼ30 s) ventricular tachycardia/ventricular fibrillation.
Optical recordings were made during steady-state pacing and during programmed stimulation. In three hearts, after programmed stimulation, an endocardial cryoablation procedure was performed to determine the influence of viable myocardial layers below the scar, using techniques described previously to maintain a viable epicardial layer (8) . After all optical mapping studies, hearts were stained with TTC (2,3,5-triphenyltetrazolium chloride) to verify epicardial viability.
Data analysis. Using previously described automated algorithms, the time of maximum membrane potential change during the upstroke (dVm/dtmax) was assigned for each action potential and projected onto the epicardial surface of the heart (6). To assess electrical viability, optical action potential amplitude (peak to peak) was normalized to maximum amplitude in normal regions and measured across the entire mapping field, as our laboratory has reported previously (18) . The action potential duration (APD) was measured at 80% of resting potential.
Confocal immunofluorescence and histology. Immunostaining was performed on all rat hearts, as previously published (18) . Slides were incubated with the primary antibody rabbit anti-connexin-43 (Cx-43) polyclonal IgG antibody (Sigma, C-6219), mouse anti-␣-actin monoclonal IgM antibody (Santa Cruz Biotech, sc-58671), or rabbit antivoltage-gated Na ϩ channel (NaV1.5) polyclonal IgG antibody (Abcam, ab56240) at 4°C. Then the slides were washed with PBS and then incubated for 2 h with corresponding secondary antibody donkey anti-rabbit IgG DyLight 488 (Jackson IR) diluted in PBS with blocking serum. After washing with PBS, TO-PRO-3 iodide (Invitrogen) was added and washed. An upright spectral laser scanning confocal microscope (model TCS-SP2; Leica Microsystems, Heidelberg, Germany), equipped with 633 diode (for TO-PRO-3 iodide) and 488 argon laser (DyLight 488), was used for confocal analysis. Images were collected by sequential excitation and analyzed using Leica Confocal software. Slides from all groups were stained with hematoxylin and eosin (H&E) after deparaffinization. Cryoinjury thickness was estimated from midventricular LV cross sections.
Cell isolation and recordings. Cells were isolated from hearts using enzyme digestion and established Langendorff perfusion techniques. Briefly, rats were euthanized as described above. Hearts were excised and perfused with oxygenated, calcium-free Tyrode buffer and 1.3 mg/ml type 2 collagenase (Worthington). The region surrounding the cryolesion (epicardium to endocardium) of the heart was dissected from the rest of the ventricle at the end of the 40-min digestion period. The dissected cryolesion was transferred to a calcium-free Tyrode solution and then gently triturated to disperse the cells. Serial increments of calcium were introduced back into the myocyte suspension to a final concentration of 1.8 mM.
All cells were incubated with 1 M fluo 3-AM for 45 min. After the incubation period, cells in Tyrode were placed in a small-volume (ϳ260 l) bath chamber designed for field stimulation (RC-21BRFS, Warner Instruments). Temperature in the bath was increased to 30°C using a heater controller (TC-344B, Warner Instruments). The chamber was mounted on a stage adapter (SA-20UU, Warner Instruments), and cells were visualized using an inverted Axiovert microscope (Zeiss). Cells were stimulated at 1 Hz (1-ms duration; ϳ40 -50 mV). Calcium transients were recorded by directing fluo 3 emission fluorescence (Ͼ510 nm) to a high temporal and spatial resolution chargecoupled device camera system (PentaMAX, Princeton Instruments). Frame (sampling) rate was maintained at 2,000 frames/min, and the excitation light (480 Ϯ 10 nm) exposure for each recording was no longer than 10 s.
Statistical analysis. The unpaired t-test was used to test for statistical significance, except for multiple comparisons, when ANOVA was performed followed by Newman-Keuls post hoc analysis. A P value Ͻ0.05 was considered statistically significant. Data are presented as means Ϯ SD, unless otherwise noted. Fig. 1 is a representative example of the cryolesion scar morphology. Figure 1A is an image of the anterior surface of an MSC-treated heart with the scar in the center (dashed circle). In all hearts, H&E staining confirmed the presence of scarred myocardium ϳ30 -50% of the transmural wall. Figure 1B shows a transmural cross section of the LV wall, demonstrating the scar above normal tissue in a sham heart. Confocal imaging of ␣-actin (green) demonstrates significantly less striated cardiac myocytes in the scar compared with normal tissue below the scar. Over all experiments (Fig.  1C) , the scar thickness in the sham group (549 Ϯ 310 m) was not significantly different from the MSC-treated group (511 Ϯ 345 m).
RESULTS
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At the time of optical mapping, all MSCtreated hearts demonstrated significant Dil fluorescence in the scar (Fig. 2) . Figure 2A shows a schematic diagram of the whole heart with an image of DiI fluorescence (orange) superimposed on an image of the epicardial extent of the scar (dashed line) that was recorded at the same time using optical mapping techniques. In all hearts, DiI fluorescence was localized to discrete regions that were consistent with the sites of cell injection noted at the time of surgery. Transmural sections (Fig. 2B ) of H&E (left) and DiI (right) from two consecutive tissue slices shows DiIϩ cells within the scar (dashed line) and close to the epicardial surface. Some DiIϩ cells were also observed at deeper layers (arrow). Shown in Fig. 2C are confocal images from a region that did (MSCϩ) and did not (MSCϪ) demonstrate significant DiI fluorescence in the optical mapping image. The confocal image from the MSCϩ region revealed positive perinuclear DiI fluorescence (red), suggesting MSCs are viable. The confocal image from the MSCϪ region showed no perinuclear DiI fluorescence. These data suggest that DiI-labeled MSCs engraft and survive when directly injected into the cryoinjury, and that macroscopic engraftment is heterogeneous.
Some cells that were DiI positive in the MSCϩ region were also positive for Cx-43 (Fig. 3A) . The confocal images, which are all taken from the same scan, show DiI fluorescence (left, red), Cx-43 expression (middle, green), and their colocalization (right, merged). The top images are taken from the border zone, where MSCs are absent (MSCϪ), and Cx-43 is expressed at intercalated disks (arrows). The bottom images (Fig.  3A) are from the same confocal scan, but in an MSCϩ region of the border zone. Cx-43 expression in the scar is evident (arrows); however, the pattern of expression is not the same as that from normal myocytes (MSCϪ). In one case (asterisk), DiI and Cx-43 are colocalized in the cytoplasm. Na V 1.5 expression ( Fig. 3B ) was significantly higher in the MSCϪ region of the border zone compared with the MSCϩ region. Action potential activity associated with MSCs. Previously, our laboratory has shown that optical action potential amplitude can be used to estimate the number of cells exhibiting transmembrane potential activity from normal and scarred myocardium (17) . Therefore, to assess the electrophysiological phenotype of MSCs in situ, we directly compared optical action potential amplitude at sites with (MSCϩ) and without (MSCϪ) MSC engraftment. Shown in Fig. 4 are optical action potential amplitude (isopotential) maps, where maximum (100%) is equal to the maximum action potential measured in the normal region. At the top is a normal (without scar) Langendorff-perfused rat heart with a depiction of the mapping field (box, Fig. 4A ) and a cross section of a heart with scar indicating the depth of Di4-ANEPPS staining (Fig. 4B, red) . In this study, di-4-ANEPPS penetrated 200 -500 m into the scar. This suggests that it is unlikely that layers below the scar are influencing optical action potential measured in the scar of MSC-treated hearts or shams. It also suggests that some DiIϩ cells in the scar are not stained with di-4-ANEPPS. Below (Fig.  4C) shows a representative example of optical action potential amplitude distribution in a normal heart. The decrease in amplitude at the periphery is likely due to lens vingetting and reduced excitation light. The action potentials shown to the right indicate a normal morphology across the mapping field.
Shown in Fig. 4D is a representative example from the sham (saline injection) group. There is no evidence of normal action potential activity within the scar (dashed line), except at the scar border zone. In contrast, for an MSC-treated heart (Fig.  4E) , the isopotential map demonstrates a region of large optical action potentials with normal morphology from the central portion of the scar (sites a and b) . As shown in the image of MSC engraftment (Fig. 4F) , regions with MSCϩ cells were closely associated with increased optical action potential amplitude.
Over all experiments (Fig. 5) , the average optical action potential amplitude within the scar at sites positive for MSCs (Ͼ50% DiI fluorescence intensity) was significantly larger than sites negative for MSCs (Ͻ50% DiI fluorescence intensity) in the MSC-treated group and also compared with sites within the scar from the sham group. These results were similar for all steady-state cycle lengths tested (200, 190 , and 150 ms) and for experiments using blebbistatin (MSCϩ 61 Ϯ 2% and MSCϪ 38 Ϯ 2%; n ϭ 4, P Ͻ 0.001). The reason why action potential amplitude was nonzero in sham animals is unknown, but this could be due to a small number of surviving myocytes and residual motion artifact. APD at 80% of resting potential measured in the scar from MSCϩ regions (61.2 Ϯ 10.6 ms) was not statistically different from that measured in normal regions remote from the scar [51.4 Ϯ 15.0 ms, P ϭ nonsignificant (NS)] and from normal regions adjacent to MSCϩ regions (50.3 Ϯ 7.3 ms, P ϭ NS). Finally, there was no difference in arrhythmia inducibility between sham and treated groups (1 of 6 and 2 of 8, respectively, P ϭ NS), which was relatively low for both groups.
Mechanisms of action potential activity associated with MSCs. If optical action potentials observed in the MSCϩ region are due to MSCs that generate action potentials, then propagation should be evident. Shown in Fig. 6 are two examples demonstrating the time of dV m /dt max and absolute amplitude of optical action potentials within the mapping field of hearts treated with MSCs. In both examples, in the MSCϩ region (red), action potential dV m /dt max is near simultaneous, and amplitude is reduced. This is depicted by the large spacing between isochrone lines in the MSCϩ regions and by the simultaneous time of dV m /dt max (circles) in the optical action potentials recorded along a line that traverses the scar and MSCϩ regions (sites a-f). This suggests that action potential activity observed in the MSCϩ region is due to passive electrotonic influence. In contrast, action potential activity outside the scar exhibits propagation. Activation perpendicular to the epicardial surface (from deeper layers) could also explain simultaneous dV m /dt max in MSCϩ regions; however, pacing is from the epicardial surface just outside the scar (pacing symbol). Some of these action potentials (bottom site f) may be lower in amplitude than average for MSCϩ regions (Fig. 5) . This could be due to DiIϩ cells below the di-4-ANEPPS-stained layer (Fig. 4B) .
To determine whether action potential activity in the MSCϩ region is electrotonic activity from deeper viable layers, we performed optical mapping before and after an endocardial cryoablation procedure. Shown in Fig. 7A at the top (left) is an image of a heart cross section that was TTC stained after the endocardial ablation, to verify the absence of viable tissue below the scar and a viable epicardium. Before ablation, increased optical action potential amplitude and normal action potential morphology (sites a and b) were evident in areas of significant MSC engraftment (top right). After the ablation procedure, optical action potential activity is almost absent compared with the same region before the ablation procedure. Similar results were observed in all hearts ablated, suggesting that the mechanism of action potential activity in MSCϩ regions is passive (i.e., electrotonic). If true, then MSCϩ regions at the edge of the scar next to viable myocardium (albeit rare) should still exhibit optical action potentials after the ablation procedure. At site c (Fig. 7) , optical action potential amplitude is less reduced (50%) and has a normal morphology compared with site a (65% reduction) and site b (70% reduction) at the center of the scar.
It is possible that the endocardial ablation procedure damaged MSCs in the scar, which could also explain the elimination of optical action potential amplitude. As shown in Fig. 7B , H&E analysis in tissue samples taken near the endocardium of an ablated heart (ablated tissue) showed evidence of acute coagulation necrosis, as indicated by separation of fibers by edema fluid (red arrows) and the absence of stained nuclei within fibers. In contrast, in the cryolesion scar tissue near the epicardium, fibers with nuclei (black arrows) and the lack of edema are clearly visible, indicating that this tissue survived the endocardial ablation procedure. Moreover, the endocardial ablation procedure is performed while the epicardial surface is Fig. 7. A, top left: shows an image of an MSC-treated heart cross section stained with TTC to demonstrate the absence of viable tissue below the scar after the endocardial ablation (left). Engraftment of MSCs is heterogeneously distributed within the region of the scar (dashed line, right). The isopotential maps at the bottom demonstrate increased electrical viability within the scar before ablation (sites a and b; left) , but a significant decrease in electrical viability after ablation (right). B, left: tissue sample from the endocardium (ablated tissue) showing evidence of acute coagulation necrosis, indicated by loss of striations and nuclei in the myocardium with slight separation of the fibers by edema fluid (red arrows). Shown on the right is a representative tissue sample from the scar with no evidence of acute coagulation necrosis (black arrows). RV, right ventricle. bathed in warm oxygenated Tyrode solution, a technique our laboratory has used previously to measure normal action potential activity from the epicardial surface without influence from deeper layers (8) . Therefore, MSCs likely survived the ablation procedure.
Finally, cells were isolated from four hearts in the MSCtreated group (Fig. 8) . All cells with a normal ventricular morphology (rod shaped, striations) were DiIϪ. Upon field simulation at 1 Hz, these DilϪ cells contracted and exhibited normal calcium transients (DiIϪ, top). DiIϩ cells (MSCs) were mostly rounded and exhibited no striations. The majority of DiIϩ cells (20 out of 23) exhibited no contraction or calcium transients upon field stimulation. However, a small percentage of DiIϩ cells (3 of 23) reproducibly exhibited calcium transients in response to field stimulation without evidence of contraction. However, these calcium transients were relatively slow and were unable to capture at 1 Hz (DiIϩ, bottom). These results suggest that Dilϩ cells are not mature cardiac myocytes that can respond to normal rates and contract. Moreover, the slow calcium response is consistent with the lack of Na V 1.5 that was observed in tissue (Fig. 3) . These data provide additional evidence that DiIϩ cells in situ do not generate action potential activity, but rather contribute in a passive (i.e., electrotonic) manner.
DISCUSSION
In the present study, we investigated the in situ cellular electrophysiology of MSCs engrafted in nonischemic scarred myocardium. We found that MSCs can engraft when directly injected into the cryoinjury and are associated with evidence of action potential activity. However, these cells do not generate action potentials. The action potentials we measured could be due to a passive (i.e., electrotonic) effect from viable myocardium adjacent to and below the scar.
MSC survival and engraftment. Dil fluorescence imaging using optical mapping techniques and in tissue samples using confocal immunofluorescence suggest that MSCs engraft and survive when directly injected into the cryoinjury. However, the macroscopic engraftment is heterogeneous and limited to sites of injection at the epicardium (Fig. 2) . The heterogeneous engraftment pattern is in agreement with previous findings, when MSCs were delivered by a transendocardial route (20) and skeletal myoblasts were directly injected epicardially (6) . Therefore, despite the absence of acute ischemia, which is associated with chemical signals that could retain MSCs (9, 31), our results suggest that MSCs still engraft and survive.
Cellular electrophysiological MSCs in situ. Most cell therapy studies have focused on scar reduction, hemodynamic benefit, and safety (proarrhythmia) (1, 11) . In contrast, very few studies have investigated the electrophysiology of stem cells in situ. In the present study, we found that MSCϩ regions were associated with a larger optical action potential amplitude compared with areas devoid of MSCs. These results are consistent with our laboratory's previous studies in which MSCs were delivered intravenously during acute ischemia and were associated with enhanced action potential activity (18, 31) . Unlike these past studies, in the present study, we were able to directly correlate regions of MSC engraftment (DiI fluorescence) with optical action potential amplitude. Other laboratories have shown evidence of functional electrical integration of stem cells in the whole heart (33)(26). Roell et al. (23) showed that embryonic cardiomyocytes were associated with improved electrical viability and decreased ventricular tachycardia inducibility after cryoinjury. However, in the present study, we focused on MSCs, which have been recently shown to improve patient outcome (10) .
Electrophysiological mechanisms of MSCs in situ. Several reports suggest that MSCs differentiate into cardiac myocytes (1, 13, 25, 30) . Rota et al. (25) showed that bone marrow cells can acquire a cardiomyogenic and vascular fate after 30 days. Dai et al. (4) showed that muscle-specific and endothelial markers are present in DiIϩ MSCs at 6 mo, but not as early as 2 wk. However, even after 6 wk, these cells did not take on an adult cardiac phenotype. MSCs co-cultured with embryonic cardiomyocytes show the presence of cardiac markers (e.g., troponin and connexin), but no evidence of action potential generation (24) . The action potential activity we measured over an aggregate of DiIϩ MSCs exhibited signs of electronic influence from deep layers rather than action potential generation (Fig. 6 , reduced amplitude and simultaneous dV m /dt max ). Once deeper viable myocardial layers were eliminated by ablation, optical action potential amplitude within the scar was essentially eliminated, except at the epicardial border zone of the scar (Fig. 7) . Moreover, isolated DiIϩ cells (MSCs) did not exhibit the morphological characteristics of ventricular myocytes (rod shape, striations), nor did they demonstrate rapid calcium transients during field stimulation (Fig. 8) . These findings are supported by previous studies that have demonstrated electrotonic interactions between MSCs and cardiomyocytes (32) , and from studies that have shown optically recorded action potentials from cells that cannot generate action potentials (7) .
In the present study, confocal imaging demonstrated Cx-43 expression in DiIϩ cells (MSCs). This finding is consistent with others showing that MSCs have the ability to express Cx-43 and Cx-45 in vivo (10, 14) and in vitro (2, 19, 21, 32) . Moreover, it has been shown that MSCs are able to functionally couple with other cells (21, 32) . Studies from our group (5, 6) and others (12, 15, 23) have shown the importance of connexin expression in engrafted cells. This may explain the electrotonic influence we observed. However, the pattern of Cx-43 cellular expression (and Na V 1.5) we measured is unlike that seen in contracting host myocytes, suggesting that these cells after 3 wk are not mature, contracting, cardiac myocytes. Implications. A potentially important clinical implication of our work is that MSCs might be able to engraft, survive, and passively enhance electrical viability when directly injected into chronic myocardial scar. In addition, as in clinical trials using bone marrow cells (16, 27, 29) or purified MSCs (3, 11), we did not report an increase in arrhythmias. It is even possible that the passive electrical nature of MSCs may suppress premature ventricular contraction activity in patients (11) . However, it is unlikely that MSCs in this setting are able to generate action potential activity. Finally, it is also important to consider the loading effect MSC may have on conduction and APD (15) . We were unable to determine whether conduction was altered in normal tissue next to MSCϩ regions; however, APD was not significantly different.
Limitations. The cryoinjury model is not good for, and was not chosen to test, arrhythmia inducibility. Cryoinjury was used because arteries remain patent compared with left anterior descending coronary artery occlusion, and the location and extent of cryoinjury injury, as well as the location of cell injection relative to cryoinjury, could be reproduced across all animals. In addition, cryoinjury is not an accurate model of chronically healed myocardial infarction. However, chronic myocardial infarction in rats leads to very thin walls (thickness Ͻ 1 mm), which makes it nearly impossible to inject cells into the scar.
It is possible that optical action potentials recorded from the scar include fluorescence from active tissue below the scar. However, we show that, when hearts are superfused with di-4-ANEPPS, the staining does not exceed 500 M of depth from the epicardium (17) . Moreover, 95% of di-4-ANEPPS fluorescence is measured from a depth of Ͻ0.5 mm, even when staining is uniform across tissue depth (8) . Since the optical action potentials measured in the MSCϩ region were, at the least, 50% of the amplitude measured in normal tissue, it is very unlikely this was from deeper layers. Even if deeper layers were influencing action potential amplitude measured in the scar, this should be equal across all groups. But MSCϩ regions had significantly higher action potential amplitude compared with regions that had no MSCs (Fig. 5) . Alternatively, confocal imaging from the epicardial surface in the whole heart could be used to avoid fluorescence from deeper tissue layers (26) .
We cannot exclude paracrine effects in this study. MSCs release cytokines and growth factors that stimulate endogenous repair mechanisms (9, 28) associated with increased angiogenesis, downregulation of proapoptotic proteins, and recruitment of cardiac stem cells. That said, it is important to note that the action potential amplitude in the MSCϪ areas was the same as that in sham-treated animals, suggesting that the presence of the MSCs may be required for the electrical changes we observed.
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